Fresenius Medical Care revenue and financials
€40.45Change from previous close: +0.70%Absolute change: +€0.28
In the fiscal year ended December 2025, Fresenius Medical Care reported revenue of €19.63B (+1.51% year over year). Net income was €978.37M, a net margin of 5.0%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +1.51%
- 2025 vs 2024
- Net income growth
- +81.88%
- 2025 vs 2024
- Net margin
- 5.0%
- 2024: 2.8%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 19,628 | 19,336 | 19,454 | 19,398 | 17,619 |
| Cost of revenue | 14,599 | 14,579 | 14,529 | 14,504 | 12,846 |
| Gross profit | 5,029 | 4,757 | 4,925 | 4,894 | 4,773 |
| Selling, general and administrative | 3,033 | 3,143 | 3,196 | 3,170 | 2,773 |
| Research and development | 158 | 183 | 232 | 229 | 221 |
| Operating income | 1,870 | 1,539 | 1,524 | 1,538 | 1,904 |
| EBIT | 1,870 | 1,539 | 1,524 | 1,538 | 1,904 |
| EBITDA | 2,622 | 2,347 | 2,436 | 2,512 | 2,799 |
| Interest expense | 384 | 407 | 425 | 360 | 354 |
| Pre-tax income | 1,512 | 1,057 | 1,033 | 1,219 | 1,572 |
| Income tax | 321 | 316 | 301 | 325 | 353 |
| Net income | 978 | 538 | 499 | 673 | 969 |
| Net income to common shareholders | 978 | 538 | 499 | 673 | 969 |
| Basic EPS | 3.36 | 1.83 | 1.70 | 2.30 | 3.31 |
| Diluted EPS | 3.36 | 1.83 | 1.70 | 2.30 | 3.31 |
| Average shares (basic) | 291 | 293 | 293 | 293 | 293 |
| Average shares (diluted) | 291 | 293 | 293 | 293 | 293 |
| Dividend per share | 1.49 | 1.44 | 1.19 | 1.12 | 1.35 |